Venturi Wealth Management LLC Raises Holdings in Intuitive Surgical, Inc. $ISRG

Venturi Wealth Management LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.6% in the 2nd quarter, HoldingsChannel reports. The fund owned 1,795 shares of the medical equipment provider’s stock after purchasing an additional 79 shares during the quarter. Venturi Wealth Management LLC’s holdings in Intuitive Surgical were worth $975,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the business. Nuveen LLC purchased a new position in shares of Intuitive Surgical during the first quarter worth $1,715,899,000. Goldman Sachs Group Inc. boosted its position in shares of Intuitive Surgical by 26.1% during the first quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider’s stock worth $1,396,496,000 after buying an additional 584,375 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Intuitive Surgical by 20.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock worth $1,680,922,000 after buying an additional 566,979 shares during the period. Wellington Management Group LLP boosted its position in shares of Intuitive Surgical by 15.0% during the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after buying an additional 457,080 shares during the period. Finally, Vanguard Group Inc. boosted its position in shares of Intuitive Surgical by 1.4% during the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after buying an additional 453,335 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $448.09 on Thursday. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The stock has a market cap of $160.63 billion, a PE ratio of 62.50, a P/E/G ratio of 4.64 and a beta of 1.61. The stock’s fifty day moving average is $460.50 and its two-hundred day moving average is $499.05.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. During the same period last year, the firm earned $1.78 earnings per share. Intuitive Surgical’s quarterly revenue was up 21.4% on a year-over-year basis. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $440.69, for a total transaction of $147,631.15. Following the sale, the director owned 739 shares in the company, valued at approximately $325,669.91. The trade was a 31.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the sale, the insider owned 19,827 shares in the company, valued at $9,368,059.23. This trade represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock worth $21,716,492 over the last ninety days. Corporate insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently commented on ISRG. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. The Goldman Sachs Group reduced their price objective on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a research note on Wednesday, October 1st. Wells Fargo & Company increased their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research note on Wednesday, July 23rd. Evercore ISI reduced their price objective on Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating on the stock in a research note on Tuesday. Finally, BTIG Research reiterated a “buy” rating and issued a $571.00 price objective on shares of Intuitive Surgical in a research note on Wednesday, October 1st. Fourteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $589.43.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.